28
Participants
Start Date
January 31, 2012
Primary Completion Date
December 31, 2019
Study Completion Date
December 31, 2019
amlodipine, hydralazine, terazosin or hydrochlorothiazide
In the washout period, the Ace Inh or ARB classes of medicine(s) that are part of the patient's antihypertensive regimen will be discontinued. The patient will be started on alternative therapy with medications that are approved by the Food and Drug Administration for treatment of high blood pressure (such as amlodipine, hydralazine, terazosin or Hydrochlorothiazide) for control of their blood pressure.
Tulane University Health Sciences Center, New Orleans
Tulane University School of Medicine
OTHER